Halin da ake ciki
 Halin da ake ciki | |
|---|---|
| Bayanai | |
| Iri | kamfani |
Paradromics Inc. kamfani ne na kwakwalwa-kwamfuta na Amurka (BCI) wanda ke da hedikwata a Austin, Texas tare da ofishin na biyu da ke Oakland, California . [1]
Bayani na gaba ɗaya
[gyara sashe | gyara masomin]Kamfanin yana gina babban tsarin kwakwalwa-kwamfuta.[2] Wannan dubawa ya kunshi cikakken tsarin da za'a iya amfani da shi wanda ke tattara bayanan jijiyoyi kuma yana canja wurin wannan bayanan ba tare da waya ba ta hanyar fata zuwa tsarin waje, wanda hakan ke fassara bayanan cikin magana da mai amfani ya yi niyya ko shigar da kwamfuta a ainihin lokacin. Bayanai marasa ma'ana da canja wurin wutar lantarki suna tallafawa ta hanyar amintaccen hanyar haɗin bayanai na infrared da haɗin wutar lantarki.[3] Paradromics yana da niyyar magance mutanen da ke fama da mummunar rauni tare da yanayin da ba za a iya sauyawa ba kamar raunin kashin baya, bugun jini, da cututtukan neurodegenerative kamar ALS.
Tarihi
[gyara sashe | gyara masomin]An kafa Paradromics a cikin 2015 ta Shugaba Matt Angle don fassara fasahar rikodin jijiyoyi daga dakin gwaje-gwaje a Jami'ar Stanford zuwa cikakkiyar hanyar da ba ta da amfani don amfani da ita azaman na'urar kiwon lafiya ta kasuwanci. A cikin shekaru biyu na farko, Paradromics ta sami NIH SBIR da kwangilar DARPA, [4] gabaɗaya sun kai dala miliyan 15. [5] Wannan tabbatarwa ta farko ta ba da damar ci gaban ainihin fasaharta da kuma tara kudaden kasuwanci a cikin 2018.
A ƙarshen 2019, Paradromics ya canza daga kamfani mai mai da hankali kan fasaha wanda ke haɓaka ƙwarewar ƙwarewa zuwa kamfani mai da hankali ga samfurin da ke gina na'urar kiwon lafiya mai sayarwa, Connexus Brain-Computer Interface (BCI).
A cikin 2021, an ba Paradromics tallafin SBIR na dala miliyan 3.2 daga NIH don haɓaka tsararru na microelectrode na intracortical don aikace-aikacen asibiti. Wannan tallafin ya haɗa da haɗin gwiwa tare da Cibiyar Nazarin Neurotechnology da Neurorecovery ta Babban Asibitin Massachusetts, yana nuna jajircewar Paradromics don ci gaba da binciken asibiti da aikace-aikacen fasaharta.
A cikin 2023, kamfanin ya tara dala miliyan 33 na kasuwanci wanda Firayim Minista Movers Lab ke jagoranta tare da shiga daga Westcott Investment Group, Dolby Family Ventures, da Green Sands Equity.[6] Connexus BCI an ba shi lambar yabo ta farko ta Breakthrough Device Designation ta Hukumar Abinci da Magunguna ta Amurka (FDA), wanda ke ba da tsari mai sauri don na'urorin kiwon lafiya masu canzawa tare da yiwuwar magance yanayin da ba za a iya sauyawa ba.[7] Aikace-aikacen farko na Connexus BCI na'urar sadarwa ce mai taimakawa wacce ke fassara siginar kwakwalwa zuwa magana da motsi a ainihin lokacin, dawo da haɗin zamantakewa da kuma ba da damar shiga kai tsaye tare da fasaha.[8]
A cikin 2024, an ba Connexus BCI lambar yabo ta biyu ta Breakthrough Device Designation wanda zai ba da damar mutanen da ke da mummunan raunin motsi da aka yi musu da Connexus BCi don sarrafa na'urorin kwamfuta.[9] An kuma yarda da Paradromics a cikin sabon shirin FDA na Amurka don na'urori masu kirkiro, TAP (Total Product Life Cycle Advisory Program) Pilot. FDA ta bayyana cewa an yi wannan shirin ne don "taimaka wajen bunkasa ci gaba da sauri da kuma samun damar haƙuri da aminci, tasiri, na'urorin kiwon lafiya masu inganci na muhimmancin kiwon lafiyar jama'a".[10]
Fasahar
[gyara sashe | gyara masomin]Kamfanin yana gina tsarin kwakwalwa-kwamfuta wanda zai iya yin rikodin daga neurons guda ɗaya. Duhu, wanda ake kira Connexus BCI, ya ƙunshi Cortical Module, Internal Transceiver, da jagorar haɗi. Cortical Module an sanya shi ta hanyar tiyata ta hanyar likitan kwakwalwa a saman kwakwalwa da ke cikin Motar cortex. Tsarin yana amfani da dabarar tiyata mai kama da na DBS.[1] Cortical Module ya ƙunshi jerin wutar lantarki na 421-channel microwire, tare da wutar lantarki 421 kusan 1.55 mm tsawo (0.06 inci) wanda ya shimfiɗa a ƙasa da farfajiyar kwakwalwa don tattara siginar jijiya kai tsaye. Microelectrodes sun fi gashin gashin mutum (<40 μm diamita). [2] Tsarin yana tallafawa har zuwa Modules Cortical guda huɗu, jimlar har zuwa 1684 intracortical electrodes.
Wannan bayanan ya wuce daga Cortical Module zuwa Internal Transceiver tare da mAI laushi, mai sassauƙa. Daga nan ana watsa shi ba tare da waya ba daga Mai karɓar ciki zuwa Mai karɓar waje mai karɓa ta hanyar hanyar haɗin bayanai na infrared wanda ke tallafawa 100 Mbit / s. Ana ci gaba da amfani da tsarin ta hanyar haɗuwa. Wannan ci gaba da gudana na bayanai sa'an nan kuma ya wuce zuwa ƙaramin na'urar lissafi wanda ke amfani da AI, ilmantarwa na inji, da samfuran harshe masu ci gaba don fassarar ainihin lokacin magana da mai amfani ya yi niyya ko shigarwar kwamfuta.
Gabaɗaya, tsarin zai yi aiki ta hanyar karanta siginar kwakwalwar mai haƙuri don fassara jawabin da suka yi niyya.
Gwaje-gwaje
[gyara sashe | gyara masomin]Gwajin Preclinical na Paradromics' Connexus Brain-Computer Interface ya nuna wani bit rate wuce 200 bps tare da tsarin latitude na 56 ms. A watan Nuwamba 2025, kamfanin ya sami FDA Investigational Device Exemption (IDE) amincewa don gwajin asibiti na farko a cikin mutum.
Manazarta
[gyara sashe | gyara masomin]- ↑ Drew, Liam (February 2023). "Decoding the business of brain–computer interfaces". Nature Electronics (in Turanci). 6 (2): 90–95. doi:10.1038/s41928-023-00929-9. ISSN 2520-1131.
- ↑ Welle, Elissa (25 July 2022). "Four brain-computer interface companies you should watch (other than Neuralink)". STAT.
- ↑ "Inside Paradromics, the Neuralink competitor hoping to commercialize brain implants before the end of the decade". CNBC (in Turanci). 20 June 2024.
- ↑ "Towards a High-Resolution, Implantable Neural Interface". www.darpa.mil.
- ↑ Hatmaker, Taylor (10 July 2017). "DARPA awards $65 million to develop the perfect, tiny two-way brain-computer interface". TechCrunch.
- ↑ "Paradromics reels in $33M, FDA breakthrough tag for mind-reading brain implant".
- ↑ Whooley, Sean (18 May 2023). "Paradromics raises $33M, wins FDA breakthrough nod for brain-computer interface tech". MassDevice.
- ↑ Capoot, Ashley (18 May 2023). "Neuralink competitor Paradromics gets one step closer to FDA approval for its brain implant". CNBC (in Turanci).
- ↑ "Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial". CNBC. 3 July 2024.
- ↑ Center for Devices and Radiological Health (7 October 2024). "Total Product Life Cycle Advisory Program (TAP)". FDA (in Turanci). Archived from the original on October 12, 2022.